Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Chapman University (33)
- Rowan University (20)
- University of Kentucky (12)
- Liberty University (7)
- LSU Health New Orleans (6)
-
- University of Tennessee Health Science Center (6)
- Virginia Commonwealth University (5)
- University of New England (4)
- University of South Alabama (4)
- Murray State University (3)
- Nova Southeastern University (3)
- University of Connecticut (3)
- University of Nebraska - Lincoln (3)
- University of Texas Rio Grande Valley (3)
- Belmont University (2)
- City University of New York (CUNY) (2)
- Dartmouth College (2)
- James Madison University (2)
- Missouri State University (2)
- Roseman University of Health Sciences (2)
- The University of Akron (2)
- Thomas Jefferson University (2)
- University of Louisville (2)
- University of Tennessee, Knoxville (2)
- Wayne State University (2)
- Advocate Health - Midwest (1)
- Arcadia University (1)
- California Polytechnic State University, San Luis Obispo (1)
- DePaul University (1)
- Eastern Washington University (1)
- Keyword
-
- Alzheimer’s disease (11)
- Inflammation (8)
- Blood-Brain Barrier (7)
- Neurodegeneration (7)
- Rats (7)
-
- Stroke (6)
- Male (5)
- Neurons (5)
- Alzheimer Disease (4)
- Blood-brain barrier (4)
- Cerebral microbleeds (4)
- Cerebral microhemorrhage (4)
- Dementia (4)
- Neuroprotection (4)
- Neuroscience (4)
- Aging (3)
- Alzheimer's Disease (3)
- Animals (3)
- Blood–brain barrier (3)
- CNS (3)
- Clinical trial (3)
- Cognition (3)
- Concussion (3)
- Cytokines (3)
- Female (3)
- Humans (3)
- Mice (3)
- Multiple sclerosis (3)
- Neurodegenerative Diseases (3)
- Neuroinflammation (3)
- Publication Year
- Publication
-
- Pharmacy Faculty Articles and Research (24)
- Rowan-Virtua Research Day (14)
- Theses and Dissertations (ETD) (6)
- Senior Honors Theses (5)
- Rowan-Virtua School of Osteopathic Medicine Departmental Research (4)
-
- Theses and Dissertations--Neuroscience (4)
- Brain Blast (3)
- Physical Therapy Faculty Articles and Research (3)
- School of Graduate Studies Faculty Publications (3)
- School of Medicine Faculty Publications (3)
- Annual Research Symposium (2)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (2)
- Communication Sciences and Disorders Faculty Articles and Research (2)
- Dartmouth Scholarship (2)
- Department of Cancer Biology Faculty Papers (2)
- Graduate School of Biomedical Sciences Theses and Dissertations (2)
- Graduate Theses/Dissertations (2)
- Honors College Theses (2)
- Honors Scholar Theses (2)
- Honors Theses (2)
- Jay Reddy Publications (2)
- Medical Student Research Symposium (2)
- Neuroscience Faculty Publications (2)
- Pursuit - The Journal of Undergraduate Research at The University of Tennessee (2)
- Research Colloquium (2)
- Senior Honors Projects, 2010-2019 (2)
- Theses and Dissertations (2)
- VCU's Medical Journal Club: The Work of Future Health Professionals (2)
- Williams Honors College, Honors Research Projects (2)
- Biology Student Publications (1)
- Publication Type
- File Type
Articles 151 - 155 of 155
Full-Text Articles in Medical Neurobiology
A Novel And Generalizable Organotypic Slice Platform To Evaluate Stem Cell Potential For Targeting Pediatric Brain Tumors., Shengwen Calvin Li, William Gunter Loudon
A Novel And Generalizable Organotypic Slice Platform To Evaluate Stem Cell Potential For Targeting Pediatric Brain Tumors., Shengwen Calvin Li, William Gunter Loudon
Department of Cancer Biology Faculty Papers
Brain tumors are now the leading cause of cancer-related deaths in children under age 15. Malignant gliomas are, for all practical purposes, incurable and new therapeutic approaches are desperately needed. One emerging strategy is to use the tumor tracking capacity inherent in many stem cell populations to deliver therapeutic agents to the brain cancer cells. Current limitations of the stem cell therapy strategy include that stem cells are treated as a single entity and lack of uniform technology is adopted for selection of clinically relevant sub-populations of stem cells. Specifically, therapeutic success relies on the selection of a clinically competent …
Heme Deficiency In Alzheimer's Disease: A Possible Connection To Porphyria, Barney E. Dwyer, Meghan L. Stone, Xiongwei Zhu, George Perry, Mark A. Smith
Heme Deficiency In Alzheimer's Disease: A Possible Connection To Porphyria, Barney E. Dwyer, Meghan L. Stone, Xiongwei Zhu, George Perry, Mark A. Smith
Dartmouth Scholarship
Mechanisms that cause Alzheimer's disease (AD), an invariably fatal neurodegenerative disease, are unknown. Important recent data indicate that neuronal heme deficiency may contribute to AD pathogenesis. If true, factors that contribute to the intracellular heme deficiency could potentially alter the course of AD. The porphyrias are metabolic disorders characterized by enzyme deficiencies in the heme biosynthetic pathway. We hypothesize that AD may differ significantly in individuals possessing the genetic trait for an acute hepatic porphyria. We elaborate on this hypothesis and briefly review the characteristics of the acute hepatic porphyrias that may be relevant to AD. We note the proximity …
Myelin Proteolipid Protein-Specific Cd4+ Cd25+ Regulatory Cells Mediate Genetic Resistance To Experimental Autoimmune Encephalomyelitis, Jay Reddy, Zsolt Illés, Xingmin Zhang, Jeffrey Encinas, Jason Pyrdol, Lindsay Nicholson, Raymond A. Sobel, Kai W. Wucherpfennig, Vijay K. Kuchroo, James P. Allison
Myelin Proteolipid Protein-Specific Cd4+ Cd25+ Regulatory Cells Mediate Genetic Resistance To Experimental Autoimmune Encephalomyelitis, Jay Reddy, Zsolt Illés, Xingmin Zhang, Jeffrey Encinas, Jason Pyrdol, Lindsay Nicholson, Raymond A. Sobel, Kai W. Wucherpfennig, Vijay K. Kuchroo, James P. Allison
Jay Reddy Publications
SJL mice are highly susceptible to experimental autoimmune encephalomyelitis (EAE) induced with myelin proteolipid protein (PLP) peptide 139–151, whereas H-2 congenic B10.S mice are resistant. Immunodominance and susceptibility to EAE are associated with a high precursor frequency of PLP 139–151-specific T cells in the naive repertoire of SJL mice. To understand the mechanism of EAE resistance in B10.S mice, we determined the precursor frequency of PLP 139–151-reactive T cells in both strains by using IAs/PLP 139–151 tetramers. SJL and B10.S mice had similar frequencies of tetramer-reactive T cells in the naive peripheral repertoire. However, in SJL mice, the …
Modified Amino Acid Copolymers Suppress Myelin Basic Protein 85–99-Induced Encephalomyelitis In Humanized Mice Through Different Effects On T Cells, Zsolt Illés, Joel N.H. Stern, Jay Reddy, Hanspeter Waldner, Marcin P. Mycko, Celia F. Brosnan, Stephan Ellmerich, Daniel M. Altmann, Laura Santambrogio, Jack L. Strominger, Vijay K. Kuchroo
Modified Amino Acid Copolymers Suppress Myelin Basic Protein 85–99-Induced Encephalomyelitis In Humanized Mice Through Different Effects On T Cells, Zsolt Illés, Joel N.H. Stern, Jay Reddy, Hanspeter Waldner, Marcin P. Mycko, Celia F. Brosnan, Stephan Ellmerich, Daniel M. Altmann, Laura Santambrogio, Jack L. Strominger, Vijay K. Kuchroo
Jay Reddy Publications
A humanized mouse bearing the HLA-DR2 (DRA/DRB1*1501) pro- tein associated with multiple sclerosis (MS) and the myelin basic protein (MBP) 85–99-specific HLA-DR2-restricted T cell receptor from an MS patient has been used to examine the effectiveness of modified amino acid copolymers poly(F,Y,A,K)n and poly- (V,W,A,K)n in therapy of MBP 85–99-induced experimental auto-immune encephalomyelitis (EAE) in comparison to Copolymer 1 [Copaxone, poly(Y,E,A,K)n]. The copolymers were designed to optimize binding to HLA-DR2. Vaccination, prevention, and treatment of MBP-induced EAE in the humanized mice with copolymers FYAK and VWAK ameliorated EAE more effectively than Copolymer 1, reduced the number of pathological lesions, and …
Validation Of A Serotonin Checklist In A Parkinson’S Disease Population, Kelly Diane Darby-Holder
Validation Of A Serotonin Checklist In A Parkinson’S Disease Population, Kelly Diane Darby-Holder
Loma Linda University Electronic Theses, Dissertations & Projects
Although the distinctive pathological marker of Parkinson’s Disease is the progressive death of neurons that produce dopamine, there are also alterations in the production of quantities of other neurotransmitters, such as norepinephrine and serotonin that contribute to the disease. Parkinson’s Disease (PD) can be divided into two distinct classes based on the manifestation of motor symptoms, Type A and Type B Parkinson’s Disease. Type B PD patients often manifest symptoms in which serotonin deficiency plays an important role, which often includes a history of depression. Within the brain and spinal cord serotonin has wide spread projections, acting as an important …